Anti-CD19 STAR T-cell Therapy

CD19-targeted STAR T-cell therapy · Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD19 STAR T-cell Therapy, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia [Phase 1]